Frank J. Slack
弗兰克·斯莱克
PhD
Professor of Pathology; Director, Institute for RNA Medicine病理学教授;RNA医学研究所所长
👥Biography 个人简介
Leading microRNA cancer researcher known for elucidating miR-21 as a potent oncomiR in lung and other cancers. Pioneered anti-miR therapeutic strategies and founded the Institute for RNA Medicine at Harvard/BIDMC.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
miR-21 in Cancer
Established miR-21 as a key oncogenic microRNA overexpressed in multiple cancers and driving tumor growth by repressing PTEN and PDCD4 tumor suppressors.
Anti-miR Therapeutics
Demonstrated that anti-miR oligonucleotides can suppress oncomiRs in vivo, laying groundwork for RNA-based cancer therapeutics now in clinical development.
Representative Works 代表性著作
A microRNA in a multiple-turnover RNAi enzyme complex
Science (2004)
Early mechanistic work on microRNA incorporation into RISC complex.
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
Cancer Research (2005)
First demonstration of miR-21 as an oncomiR protecting cancer cells from apoptosis.
Oncomir addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
Nature (2010)
In vivo evidence that miR-21 drives lymphomagenesis and tumors regress upon miR-21 inhibition.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Faisal Mahmood
Brigham and Women's Hospital; Harvard Medical School
Kun-Hsing Yu
Harvard Medical School; Brigham and Women's Hospital
Ziad Obermeyer
University of California, Berkeley; UC San Francisco
Andrew H. Beck
PathAI; Harvard Medical School (formerly)
关注 弗兰克·斯莱克 的研究动态
Follow Frank J. Slack's research updates
留下邮箱,当我们发布与 Frank J. Slack(Harvard Medical School / Beth Israel Deaconess Medical Center)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment